glp 1 news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD GLP-1 weight loss drugs leave

Recent clinical studies suggest that Zepbound (tirzepatide) may have a higher success rate in promoting weight loss compared to Wegovy ( semaglutide GLP-1 )

Studies document enhanced angiogenesis with increased blood vessel formation in wound beds, providing better oxygen and nutrient delivery to healing tissues

Another intervention that has been helpful in some cases is the peptide BPC-157

What makes BPC-157 different is not that peptide medicine is impossible

L-carnitine and the heart Because the carnitine level in the failing heart muscle is low, additional amounts can counteract the toxic effects of free fatty acids and improve the carbohydrate metabolism

For people struggling with weight, GLP-1 levels or signaling may be lower, contributing to increased hunger